Natural history of progressive supranuclear palsy: A clinicopathologic study from a population of brain donors

European Neurology

Volumn 54, Issue 1, 2005, Pages 1-9

  Papapetropoulos, Spiridon ^a   Gonzalez, Jocely ^a   Mash, Deborah C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Brain donors; Neuropathology; Postmortem; Progressive supranuclear palsy

Indexed keywords

AGED; ARTICLE; AUTOPSY; BRAIN; CONTROLLED STUDY; DEMENTIA; FALLING; FEMALE; HUMAN; HUMAN TISSUE; MALE; ONSET AGE; ORGAN DONOR; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SMOKING;

AGE FACTORS; AGE OF ONSET; AGED; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCULOSKELETAL EQUILIBRIUM; SMOKING; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 24944566320     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086754     Document Type: Article

References (61)

1. Steele JC, Richardson JC, Olszewski J: Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-359.
2. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I: Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-2019.
3. Blin J, Baron JC, Dubois B, Pillon B, Cambon H, Cambier J, Agid Y: Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol 1990;47:747-752.
4. Golbe LI, Davis PH: Progressive Supranuclear Palsy. Baltimore, Williams and Wilkins, 1993.
5. Lees AJ: The Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy); in Marsden CD, Fahn S (eds): Movement Disorders 2. London, Butterworth and Co, 1987, p 272-287.
6. Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, Wenning G, D'Olhaberriague L, Verny M, Chaudhuri KR, McKee A, Jellinger K, Bartko JJ, Mangone CA, Pearce RK: Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 1996;46:922-930.
7. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW: Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97-105.
8. Litvan I, Grimes DA, Lang AE, Jankovic J, McKee A, Verny M, Jellinger K, Chaudhuri KR, Pearce RK: Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999;246(suppl 2):1-5.
9. Litvan I, Campbell G, Mangone CA, Verny M, McKee A, Chaudhuri KR, Jellinger K, Pearce RK, D'Olhaberriague L: Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain 1997;120:65-74.
10. Gearing M, Olson DA, Watts RL, Mirra SS: Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 1994;44:1015-1024.
11. Verny M, Jellinger KA, Hauw JJ, Bancher C, Litvan I, Agid Y: Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathol (Berl) 1996;91:427-431.
12. Lopez OL, Litvan I, Catt KE, Stowe R, Klunk W, Kaufer DI, Becker JT, DeKosky ST: Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 1999;53:1292-1299.
13. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM: Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 1995;58:167-173.
14. Tolosa E, Valldeoriola F, Marti MJ: Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neural Transm Suppl 1994;42:15-31.
15. Osaki Y, Ben-Shlomo Y, Lees AJ, Daniel SE, Colosimo C, Wenning G, Quinn N: Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 2004;19:181-189.
16. Josephs KA, Dickson DW: Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov Disord 2003;18:1018-1026.
17. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
18. Folstein MF, Folstein SE, McHugh PR: 'Minimental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
19. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
20. American Psychiatric Association: Diagnostic and Statistical Manual for Psychiatric Disorders, ed 3, revised. Washington, American Psychiatric Association, 1987.
21. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 2000.
22. Birdi S, Rajput AH, Fenton M, Donat JR, Rozdilsky B, Robinson C, Macaulay R, George D: Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases. Mov Disord 2002;17:1255-1264.
23. Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC: Prevalence and natural history of progressive supranuclear palsy. Neurology 1988;38:1031-1034.
24. Jackson JA, Jankovic J, Ford J: Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Ann Neurol 1983;13:273-278.
25. Steele JC: Progressive supranuclear palsy. Brain 1972;95:693-704.
26. Brusa A, Mancardi GL, Bugiani O: Progressive supranuclear palsy 1979: an overview. Ital J Neurol Sci 1980;1:205-222.
27. Jellinger K, Riederer P, Tomonaga M: Progressive supranuclear palsy: clinico-pathological and biochemical studies. J Neural Transm Suppl 1980:111-128.
28. Litvan I, Mangone CA, McKee A, Verny M, Parsa A, Jellinger K, D'Olhaberriague L, Chaudhuri KR, Pearce RK: Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996;60:615-620.
29. De Bruin VM, Lees AJ: Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olszewski and other related syndromes: a review of 90 pathologically verified cases. Mov Disord 1994;9:381-389.
30. Riley DE, Lang AE, Lewis A, Resch L, Ashby P, Hornykiewicz O, Black S: Cortical-basal ganglionic degeneration. Neurology 1990;40:1203-1212.
31. Gibb WR, Luthert PJ, Marsden CD: Cortico-basal degeneration. Brain 1989;112:1171-1192.
32. Duvoisin RC, Golbe LI, Lepore FE: Progressive supranuclear palsy. Can J Neurol Sci 1987;14:547-554.
33. Kristensen MO: Progressive supranuclear palsy - 20 years later. Acta Neurol Scand 1985;71:177-189.
34. Quinn NP: Parkinson's disease: clinical features; in Quinn NP (ed): Clinical Neurology-Parkinsonism. London, Bailliere Tindall, 1997, pp 1-13.
35. Daniel SE, de Bruin VM, Lees AJ: The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995;118:759-770.
36. Nath U, Ben-Shlomo Y, Thomson RG, Lees AJ, Burn DJ: Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology 2003;60:910-916.
37. Kida E, Barcikowska M, Niemczewska M: Immunohistochemical study of a case with progressive supranuclear palsy without ophthalmoplegia. Acta Neuropathol (Berl) 1992;83:328-332.
38. Jankovic J: Progressive supranuclear palsy. Clinical and pharmacologic update. Neurol Clin 1984;2:473-486.
39. Nieforth KA, Golbe LI: Retrospective study of drug response in 87 patients with progressive supranuclear palsy. Clin Neuropharmacol 1993;16:338-346.
40. Kompoliti K, Goetz CG, Litvan I, Jellinger K, Verny M: Pharmacological therapy in progressive supranuclear palsy. Arch Neurol 1998;55:1099-1102.
41. Golbe LI: Progressive supranuclear palsy in the molecular age. Lancet 2000;356:870-871.
42. Maher ER, Lees AJ: The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1986;36:1005-1008.
43. Pfaffenbach DD, Layton DD, Jr., Kearns TP: Ocular manifestations in progressive supranuclear palsy. Am J Ophthalmol 1972;74:1179-1184.
44. Davis PH, Bergeron C, McLachlan DR: Atypical presentation of progressive supranuclear palsy. Ann Neurol 1985;17:337-343.
45. Perkin GD, Lees AJ, Stern GM, Kocen RS: Problems in the diagnosis of progressive supranuclear palsy. (Steele-Richardson-Olszewski syndrome). Can J Neurol Sci 1978;5:168-173.
46. Chamberlain W: Restriction in upward gaze with advancing age. Am J Ophthalmol 1971;1:341-346.
47. Chamberlain W: Restriction in upward gaze with advancing age. Trans Am Ophthalmol Soc 1970;68:234-244.
48. Barclay CL, Lang AE: Dystonia in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1997;62:352-356.
49. Litvan I, Sastry N, Sonies BC: Characterizing swallowing abnormalities in progressive supranuclear palsy. Neurology 1997;48:1654-1662.
50. Janati A, Appel AR: Psychiatric aspects of progressive supranuclear palsy. J Nerv Ment Dis 1984;172:85-89.
51. Golbe LI: Progressive supranuclear palsy. Curr Treat Options Neurol 2001;3:473-477.
52. Fabbrini G, Barbanti P, Bonifati V, Colosimo C, Gasparini M, Vanacore N, Meco G: Donepezil in the treatment of progressive supranuclear palsy. Acta Neurol Scand 2001;103:123-125.
53. Scaravilli T, Pramstaller PP, Salerno A, Egarter-Vigl E, Giometto B, Vitaliani R, An SF, Revesz T: Neuronal loss in Onuf's nucleus in three patients with progressive supranuclear palsy. Ann Neurol 2000;48:97-101.
54. Holmberg B, Kallio M, Johnels B, Elam M: Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes. Mov Disord 2001;16:217-225.
55. Santacruz P, Uttl B, Litvan I, Grafman J: Progressive supranuclear palsy: a survey of the disease course. Neurology 1998;50:1637-1647.
56. Roos RA, Jongen JC, van der Velde EA: Clinical course of patients with idiopathic Parkinson's disease. Mov Disord 1996;11:236-242.
57. Esmonde T, Giles E, Gibson M, Hodges JR: Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy. J Neurol 1996;243:638-643.
58. Papapetropoulos S, Ellul J, Polychronopoulos P, Chroni E: A registry-based, case control investigation of Parkinson's disease with and without cognitive impairment. Eur J Neurol 2004;11:347-351.
59. Marder K, Leung D, Tang M, Bell K, Dooneief G, Cote L, Stern Y, Mayeux R: Are demented patients with Parkinson's disease accurately reflected in prevalence surveys? A survival analysis. Neurology 1991;41:1240-1243.
60. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P: Smoking and lung cancer survival: the role of comorbidity and treatment. Chest 2004;125:27-37.
61. Maraganore DM, Anderson DW, Bower JH, McDonnell SK, Rocca WA: Autopsy patterns for Parkinson's disease and related disorders in Olmsted County, Minnesota. Neurology 1999;53:1342-1344.